AG Ventures (506579)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 0.43 offers a deep discount to stated book value of ₹264.53.
• Latest quarter remains profitable with sales of ₹31 Cr and net profit of ₹2 Cr.
• Sales growth of 5.03% shows modest topline momentum despite weak earnings.
• Small market cap of ₹114 Cr and asset backing may attract special-situation or control investors.

Concerns

• ROE of 1.62% and ROCE of 0.77% reveal very poor returns on capital employed.
• Profit growth is negative at -6.49%, and Piotroski F-Score of 4/9 signals weak financial health.
• P/E of 19 is not cheap for a business with falling profits; PEG of 3.78 is unfavorable.
• Zero dividend yield and undisclosed promoter holding/debt data increase minority-investor uncertainty.

AI Analysis

Let's look at AG Ventures. At ₹113.75, I'm being offered a stake with book value of ₹264.53—for every rupee of ownership in the business, the market asks only 43 paise. That sounds like Graham's margin of safety. But Benjamin Graham also told us to distinguish between a bargain and a value trap. Here the earning power is weak: return on equity is just 1.62%, and return on capital employed only 0.77%. With profits down 6.49% and sales growth of 5.03%, this is not a compounding machine. A P/E of 19 for falling earnings is not cheap; with negative profit growth, the PEG of 3.78 is hardly reassuring. The Piotroski score of 4 out of 9 whispers financial deterioration, not healing. Dividend yield is zero—so shareholders are not being paid to wait. In commodity chemicals, there is rarely a moat; prices are set by global cycles and capacity. So what am I buying? Hard assets, perhaps, at a discount. But if those assets only generate 1.62% ROE, book value is of limited use. A plain Graham analysis might see downside protection in net assets, but I need evidence that management can redeploy capital profitably. That evidence is missing. I do not invent data; promoter holding and debt details are unavailable, which is itself a red flag for minority investors. I will wait and watch whether operating returns recover. If commodity prices turn and ROCE moves toward double digits, this could become an interesting asset play. Today, however, a discount to book is not enough. I prefer a wonderful business at a fair price to a mediocre business at a seemingly low price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer